XERS
Xeris BiopharmaยทNASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
XERS Profile
Xeris Biopharma Holdings, Inc.
A biopharmaceutical company that develops therapies for endocrinology, neurology, and gastroenterology
180 N. LaSalle Street, Suite 1300, Chicago, Illinois 60607
--
Xeris Biopharma Holdings, Inc., was incorporated in 2005 under the laws of the State of Delaware. The company is committed to building an innovative, self-sustaining, growth-oriented biopharmaceutical company dedicated to improving the lives of patients by developing and commercializing clinically meaningful products in a range of therapies. The company is uniquely positioned to achieve this with three commercial products and proprietary formulation science (XeriSol and XeriJect) to build partnerships and enhance product candidates.
